Andres A - Search Results

1

Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition.

Praga M, Borstein B, Andres A, Arenas J, Oliet A, Montoyo C, Ruilope LM, Rodicio JL. Praga M, et al. Among authors: andres a. Am J Kidney Dis. 1991 Mar;17(3):330-8. doi: 10.1016/s0272-6386(12)80483-5. Am J Kidney Dis. 1991. PMID: 1996578

2

Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.

Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL. Praga M, et al. Among authors: andres a. Am J Kidney Dis. 1992 Sep;20(3):240-8. doi: 10.1016/s0272-6386(12)80696-2. Am J Kidney Dis. 1992. PMID: 1519604

3

Nephrotic syndrome and focal glomerulosclerosis in adult polycystic kidney disease.

Montoyo C, Martínez MA, Campo C, Mazuecos A, Andrés A, Praga M. Montoyo C, et al. Among authors: andres a. Nephron. 1992;61(1):106-10. doi: 10.1159/000186845. Nephron. 1992. PMID: 1528329 Review.

4

Effect of captopril, an angiotensin converting enzyme inhibitor, on the massive proteinuria due to chronic rejection after renal transplantation--a prospective study.

Morales JM, Andres A, Montoyo C, Praga M, Alcazar JM, Algranati L, Rodicio JL. Morales JM, et al. Among authors: andres a. Transplant Proc. 1992 Feb;24(1):92-3. Transplant Proc. 1992. PMID: 1539354 No abstract available.

5

Tubular dysfunction in nephrotic syndrome: incidence and prognostic implications.

Praga M, Andres A, Hernandez E, Montoyo C, Mazuecos A, Campo C, Morales JM, Rodicio JL. Praga M, et al. Among authors: andres a. Nephrol Dial Transplant. 1991;6(10):683-8. doi: 10.1093/ndt/6.10.683. Nephrol Dial Transplant. 1991. PMID: 1754103

6

Effects of body-weight loss and captopril treatment on proteinuria associated with obesity.

Praga M, Hernández E, Andrés A, León M, Ruilope LM, Rodicio JL. Praga M, et al. Among authors: andres a. Nephron. 1995;70(1):35-41. doi: 10.1159/000188541. Nephron. 1995. PMID: 7617115 Clinical Trial.

7

Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.

Morales JM, Andres A, Rodriguez Paternina E, Alcazar JM, Montoyo C, Rodicio JL. Morales JM, et al. Among authors: andres a. Transplant Proc. 1992 Feb;24(1):89-91. Transplant Proc. 1992. PMID: 1347185 Clinical Trial. No abstract available.

8

Does calcium antagonist improve established early ciclosporin nephrotoxicity after renal transplantation?

Morales JM, Andres A, Montoyo C, Ortuño B, Rodicio JL. Morales JM, et al. Among authors: andres a. Nephron. 1991;57(2):227-9. doi: 10.1159/000186256. Nephron. 1991. PMID: 2020352

9

Diuretic and natriuretic properties of fenoldopam in chronic renal failure.

Andrés A, García-Robles R, Alcázar JM, Alvarez C, Martínez J, Oliet A, Sancho J, Rodicio JL, Ruilope LM. Andrés A, et al. J Hypertens Suppl. 1989 Dec;7(6):S326-7. doi: 10.1097/00004872-198900076-00159. J Hypertens Suppl. 1989. PMID: 2576671

10

Characterization of the renal effects of an intravenous calcium gluconate infusion in normotensive volunteers.

Ruilope LM, Oliet A, Alcázar JM, Hernández E, Andrés A, Rodicio JL, García-Robles R, Martínez J, Lahera V, Romero JC. Ruilope LM, et al. Among authors: andres a. J Hypertens Suppl. 1989 Dec;7(6):S170-1. doi: 10.1097/00004872-198900076-00081. J Hypertens Suppl. 1989. PMID: 2632708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,260 results

Search Page

Filters